Abstract
Introduction: The SCAN lung cancer workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for the use of systemic therapy in advanced non-small cell lung cancer (NSCLC) in Singapore. Materials and Methods: The workgroup utilised a modified ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. Results: Five international guidelines were evaluated—those developed by the National Comprehensive Cancer Network (2014), the European Society of Medical Oncology (2014), the National Institute of Clinical Excellence (2012), the Scottish Intercollegiate Guidelines Network (2014) and Cancer Care Council Australia (2012). Recommendations on systemic treatment for advanced NSCLC were produced. Conclusion: These adapted guidelines form the SCAN guidelines 2015 for systemic therapy of advanced or metastatic NSCLC.
Key words: ADAPTE process, Asian population, Chemotherapy, Targeted therapy
Publisher
Academy of Medicine, Singapore
Reference50 articles.
1. Health Promotion Board, Singapore. National Registry of Disease Office. Singapore cancer registry interim annual registry report—trends in cancer incidence in Singapore 2008-2012. Singapore, Health Promotion Board, 2013.
2. Fervers B, Burgers JS, Haugh MC, Latreille J, Mlika-Cabanne N, Paquet L, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care 2006;18:167-76.
3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology—non-small cell lung cancer version 4.2014. Available at: http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed on 1 March 2014.
4. Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23 Suppl 7:vii56-64.
5. National Institute for Health and Care Excellence, United Kingdom. NICE Pathway—treatment for non-small-cell lung cancer. Available at: pathways.nice.org.uk/pathways/lung-cancer. Accessed on 1 March 2014.